antibody-drug conjugate
PulseAugur coverage of antibody-drug conjugate — every cluster mentioning antibody-drug conjugate across labs, papers, and developer communities, ranked by signal.
- 2026-06-02 research_milestone A clinical trial demonstrated that a new antibody-drug conjugate can shrink tumors and slow disease progression in patients with advanced uterine cancer. source
1 day(s) with sentiment data
-
Samsung Biologics to acquire PolyPeptide Group for CHF 1.46B
Samsung Biologics has announced its intention to acquire PolyPeptide Group AG for CHF 1.46 billion in an all-cash deal. This strategic move aims to expand Samsung Biologics' capabilities beyond antibody and antibody-dru…
-
New targeted drug offers improved outcomes for aggressive breast cancer
A new antibody-drug conjugate has shown promising results in a clinical trial for aggressive triple-negative breast cancer. The targeted therapy, which combines an antibody with chemotherapy, significantly extended prog…
-
New targeted drug shrinks uterine cancer tumors in clinical trial
A novel antibody-drug conjugate has shown promise in treating advanced uterine cancer, shrinking tumors and slowing disease progression in a recent clinical trial. This targeted therapy delivers chemotherapy directly to…